Infusystems Story

<div class='circular--portrait' style='background:#169D0B;color: #FFFFF0;font-size:4em;'>IH</div>
INFU -- USA Stock  

USD 21.84  0.14  0.65%

Infusystems Holdings Debt to Equity Ratio is comparatively stable at the moment as compared to the past year. Infusystems Holdings reported Debt to Equity Ratio of 2.93 in 2020. EBITDA Margin is likely to gain to 0.24 in 2021, whereas Invested Capital Average is likely to drop slightly above 82.9 M in 2021. Infusystems Holdings is scheduled to announce its earnings today. The stock is currently undergoing an active upward rally. While some of us are excited about healthcare space, let's try to review Infusystems Holdings in greater detail to make a better evaluation of its fundamental indicators. I will address the reasons this entity was abused by private investors resulted from the current market uncertainty. We currently estimate Infusystems Holdings as fairly valued. The real value is approaching 19.26 per share.
Published over three weeks ago
View all stories for Infusystems Holdings | View All Stories
How stable are Infusystems Holdings (NYSEMKT:INFU) technical and fundamental indicators given the newest gain?
Our trade recommendations module complements current analysts and expert consensus on Infusystems Holdings. It analyzes the firm potential to grow using all fundamental, technical, and market related data available at the time.
Typically, a company's financial statements are the reports that show the financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Infusystems Holdings income statement, its balance sheet, and the statement of cash flows. Potential Infusystems Holdings investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Infusystems Holdings investors may use each financial statement separately, they are all related. The changes in Infusystems Holdings's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Infusystems Holdings's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
The goal of Infusystems Holdings fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Infusystems Holdings performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Infusystems Holdings shares is the value that is considered the true value of the share. If the intrinsic value Infusystems is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Infusystems Holdings.
Please read more on our fundamental analysis page.

How important is Infusystems Holdings's Liquidity

Infusystems Holdings financial leverage refers to using borrowed capital as a funding source to finance Infusystems Holdings ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Infusystems Holdings financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Infusystems Holdings's total debt and its cash.

How Infusystems utilizes its cash?

To perform a cash flow analysis of Infusystems Holdings, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Infusystems Holdings is receiving and how much cash it distributes out in a given period. The Infusystems Holdings cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Infusystems Holdings Net Cash Flow from Operations is comparatively stable at the moment as compared to the past year. Infusystems Holdings reported Net Cash Flow from Operations of 20.28 Million in 2020

Infusystems Holdings Gross Profit

Infusystems Holdings Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Infusystems Holdings previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Infusystems Holdings Gross Profit growth over the last 10 years.
Please check Gross Profit in more details.

What is driving Infusystems Holdings Investor Appetite?

There are few distinct groups of Infusystems Holdings stakehholders that the SEC considers insiders. Investors usually gain information through their work as corporate directors, officers, or employees. If these individuals share the information with a friend, family, or business partner and the person who receives the information exchanges stock in the company, he or shie is also an insider. Let's take a look at how the ownership of Infusystems is distributed among investors.

Ownership Allocation

Infusystems Holdings secures a total of 20.24 Million outstanding shares. Over half of Infusystems Holdings outstanding shares are owned by outside corporations. These outside corporations are typically referred to corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulation than regular investors in Infusystems Holdings. Please watch out for any change in the institutional holdings of Infusystems Holdings as this could mean something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.


Retail Investors
26.33%
Institutions
69.66%
Retail Investors26.33
Insiders4.01
Institutions69.66
 2018 2019 2020 2021 (projected)
Interest Expense1.42 M1.9 M1.71 M1.88 M
Gross Profit39.57 M46.88 M53.91 M53.1 M

Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Infusystems Holdings has an asset utilization ratio of 98.39 percent. This implies that the company is making $0.98 for each dollar of assets. An increasing asset utilization means that Infusystems Holdings is more efficient with each dollar of assets it utilizes for everyday operations.


Assets Non Current
57 M
Current Assets21.35 Million18.24
Assets Non Current56.96 Million48.68
Goodwill20.92 Million17.88
Tax Assets17.78 Million15.19

Over 3 percent gain for Infusystems Holdings. What does it mean for private investors?

Semi deviation is down to 2.4. It may call for a possible volatility drop. Infusystems Holdings currently demonstrates below-average downside deviation. It has Information Ratio of 0.06 and Jensen Alpha of 0.17. However, we advise investors to further question Infusystems Holdings expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Infusystems Holdings' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Infusystems Holdings' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Whereas some firms under the medical instruments & supplies industry are still a bit expensive, Infusystems Holdings may offer a potential longer-term growth to private investors. To summarize, as of the 17th of March 2021, we see that Infusystems Holdings almost neglects market trends. The firm is fairly valued with low chance of financial distress within the next 24 months. Our current 30 days buy-or-sell advice on the firm is Hold.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Infusystems Holdings. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com